HBI0101 CART Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Polina Stepensky2

Indications

Idiopathic Inflammatory Myopathy (IIM)1
Rheumatoid Arthritis (RA1
Systemic Sclerosis (SSc)1
Systemic Lupus Erythematosus (SLE)1
Multiple Myeloma, Relapsed1

Other2 trials

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Phase 1

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.